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Background: The insulin receptor substrate 1 (IRS1), phosphoinositide 3-kinase (Pi3k), protein kinase B (Akt1), Forkhead
Box O3a (FOXO3a) pathway is directly involved in aging and ovarian activation of follicle growth. Therefore, the aim of
this work was to measure the expression of genes related to the ovarian pathway for activation of primordial follicles
and FOXO3a protein phosphorylation between young and old female Ames dwarf (df/df) and normal (N) mice.
Methods: For this study ovaries from N (n = 10) and df/df (n = 10) female mice were collected at 5–6 months of age
and at 21–22 months of age. For immunohistochemistry ovaries from 12 month-old and df/df mice were used.
Results: The expression of Irs1, Pi3k, Akt1, mammalian target of rapamycin (Mtor), suppressor of cytokine signaling −2
(Socs2), Socs3 was lower (P < 0.05) in older than younger N mice and not different (P > 0.05) between young and old
df/df mice. The expression of Foxo3a was also lower (P < 0.05) in old than younger N and df/df mice and was higher
(P < 0.05) in old df/df than N mice. Expression of Amh was lower (P < 0.05) in old than young N and df/df mice and
was higher (P = 0.0009) in df/df than N mice. Imunnostaining for p-FOXO3 was lower in df/df than N mice (P < 0.001),
although FOXO3 immunostaining was not different (P > 0.05) between df/df and N mice.
Conclusions: In sum, the present study indicates that lower expression of Irs1, Socs2, Socs3, Akt1, Pi3k, Mtor and Foxo3a
mRNA in the ovaries of older mice of both genotypes is associated to a reduced ovarian activity revealed by lower
expression of Amh mRNA. At the same time, ovaries of old df/df mice maintained higher expression of Foxo3a mRNA,
which was associated to higher ovarian activity. We have shown that df/df females have a lower level of
p-FOXO3 in oocytes from primordial/primary follicles, an important activator of follicular growth. Therefore, this
study strongly indicates that Prop1df mutation causes delayed ovarian aging.
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The Ames dwarf mice (df/df ) carry a mutation at the
Prop1 (Prophet of Pit1) locus that impairs the develop-
ment of the anterior pituitary gland [1], resulting in defi-
ciency of growth hormone (GH), thyroid-stimulating
hormone (TSH), and prolactin [2]. As the result of the
GH deficiency these mice are characterized by severely
low circulating insulin-like growth factor I (IGF-I) and
reduced adult body size [3]. Importantly, regardless of
these hormonal deficiencies, df/df mice live 35-75% longer* Correspondence: michal.masternak@ucf.edu
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unless otherwise stated.than their normal littermates [4]. Similarly to the df/df
mice, the knockout mice with a disruption of the GH re-
ceptor gene/GH binding protein (GHRKO) and normal
mice (N) subjected to mild calorie restriction have re-
duced serum IGF-I concentrations and extended lifespan
[5,6]. At the same time transgenic mice over-expressing
GH are characterized by significant reduction of their
lifespan when comparing to their normal controls [7].
Subjecting GH-deficient df/df mice to 6 weeks of GH
replacement therapy early in life decreased the longevity
of these long-living mutants to the lifespan maintained by
N mice [8]. All these data indicate that the GH/IGF-I axis
and its intracellular mediators play a major role in the
process of aging and longevity [9]. However, regardless of
severe reduction of IGF-I in circulation it was shown thatral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Primer pairs used in the experiment
Gene Primer sequence
β2M For AAGTAT ACT CAC GCC ACC CA





SOCS2 For CTG CGC GAG CTC AGT CAA A
Rev ATC CGC AGGTTA GTC GGT CC
SOCS3 For TGT CGG AAG ACT GTC AAC GG
Rev GAA GAA GCC AAT CTG CCC CT
Akt1 For CCG GTT CTT TGC CAA CAT CG
Rev ACA CACTCC ATG CTG TCA TCT T
Pi3k For TAGCTGCATTGGAGCTCCTT
Rev TACGAACTGTGGGAGCAGAT
mTOR For CGG CAA CTT GAC CAT CCT CT
Rev TGCTGG AAG GCGTCA ATC TT
IRS-1 For CGG GGA AGA CGA GAT GCT TT
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IGF-I in the hippocampus and ovaries [10,11].
It is well established in reproductive studies that a func-
tional GH/IGF-I axis is important for normal ovarian
function [12]. Although df/df female mice are infertile,
they have normal estrous cycles and are able to ovulate
[2]. The infertility probably arises from the inability to
maintain the gestation, since normal pregnancy can be
achieved after prolactin treatment, with an average 2.6
live offspring/pregnancy [13]. Pituitary production and
circulating concentrations of follicle stimulating hormone
(FSH) and luteinizing hormone (LH) are present but re-
duced in df/df mice [14]. GHRKO mice and N mice sub-
jected to calorie restriction share several physiological
characteristics with df/df mice; however, they are able to
reproduce naturally, despite a reduced litter size, mainly
due to a reduction in the number of large follicles and the
ovulation rate [15,16]. One noteworthy point is the pro-
longed reproductive lifespan of GHRKO mice, as indi-
cated by the presence of ovarian activity at a later age,
when normal mice have already depleted the ovarian fol-
licular reserves [17]. This condition seems to occur due to
the reduction in the progression of follicles from the prim-
ordial to the primary stage in both GHRKO and calorie
restriction mice [16,18], although no reports for df/df
mice were found in the literature.
The ovarian primordial follicle reserve is established
during fetal development [19]. After birth there is a con-
tinuous activation of the primordial follicle pool which
leads to growth of individual follicles, while the rest of
the pool remain quiescent for months or even years,
until the reserve is depleted in a event known as meno-
pause. Several local factors are believed to be involved in
this activation process [19]. One of them is the activa-
tion of the phosphoinositide 3-kinase (Pi3k)/protein kin-
ase B (Akt1) signaling pathway, an important regulator
of cell proliferation and survival, that has been impli-
cated in the activation of primordial follicles [20,21]. It is
known that activation of the Pi3k/Akt1 pathway and
the downstream transcription factor Forkhead Box O3a
(FOXO3a) induced by the oocyte is a key regulator of
the activation of primordial follicles [22]. The hyperac-
tivation of Akt1 results in hyperphosphorylation and
nuclear export of FOXO3a, culminating with the global
activation of primordial follicles and premature ovarian
failure [23]. The mammalian target of rapamycin (mTOR)
pathway also has a direct relationship with activation of
the Pi3k/Akt1 pathway [24]. mTOR activation accelerates
primordial follicle activation in a synergistic way with the
Pi3k/Akt1 pathway [25]. The IRS-Pi3k-Akt1-FOXO path-
way is stimulated by both insulin and IGF-I and its reduced
activation seems to be involved in the extended longevity
observed in the mouse models mentioned before [26].
Therefore, it is possible that the extended reproductivelifespan in these mice can be also related to the compo-
nents of this pathway.
Based on these evidences the aim of this work was to
measure the expression of genes related to the ovarian
pathway for activation of primordial follicles between
young (6 months old) and old (22 months old) female
df/df and N mice and also measure the level of FOXO3
and p-FOXO3 protein in the ovaries of 12-month old N
and Ames dwarf mice.
Methods
Normal (N; n = 10) and Ames dwarf mice (df/df;
n = 10) (all females) were bred and maintained under
temperature- and light-controlled conditions (22 ± 2°C,
12 hour light/12 hour dark cycle) [27]. The animals
were anesthetized and euthanized after overnight fast-
ing and the pair of ovaries was collected and stored
at −80°C. The ovarian collection was performed at 5–6
months of age (young; 5 N and 5 df/df mice) and at
21–22 months of age (old; 5 N and 5 df/df mice).
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homogenized with 400 μL of Qiazol (Qiagen, Valencia,
CA, USA) using 0.5 mm zirconium oxide beads in the
Bullet Blender 24 (Next Advance, Averill Park, NY,
USA) for 4 minutes at speed 10. After that, 300 μL of
Qiazol were added to the samples and incubated for
5 min at room temperature. Next 170 μL of chloroform
was added, the samples were homogenized and incu-
bated for 3 min at room temperature. Samples were then
centrifuged at 4°C at 12000 g for 15 min and the clear
upper phase transferred to a new tube with 525 μL of
cold ethanol. The solution was transferred for a com-
mercial column purification system (miRNeasy Mini Kit,
Qiagen) and on-column DNase treatment (RNase-free
DNase Set, Qiagen) following manufacturer's instructionsFigure 1 Ovarian gene expression for genes in the insulin signaling p
bar) and old (22 months–grey bar) normal (N) and Ames dwarf (df/df
Expression of all genes showed was lower in old than younger mice (P<0.0was performed. The quantity of RNA was determined
using a spectrophotometer (Epoch Microplate Spectro-
photometer, Biotek, Winooski, VT, USA) and diluted to
200 ng/μL. Reverse transcription reactions were per-
formed with 1 μg of RNA (5 μL) using iScript Synthesis
Kit (Biorad, Hercules, CA, USA) in a 20 μL volume incu-
bated at 5 min at 25°C, 30 min at 42°C and 5 min at 85°C
(MJ Mini Personal Thermal Cycler, Biorad). The final
cDNA solution was diluted to 10 ng/μL before use.
Real-time PCR using SYBR Green dye was used to
evaluate gene expression. β2 microglobulin expression
was used as an internal control. The primer sequences
are listed in Table 1. The PCR reactions were performed
in duplicate in a 20 μL volume using 5 μL of Fast SYBR
Green Mastermix (Applied Biosystems, Foster City, CA,athway (IRS1, Pi3k, Akt1 and FOXO3a) in young (6 months–black
) mice. Different letter indicate significant differences (P<0.05).
5).
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cDNA. Fluorescence was quantified with the ABI Prism
7500 Fast Real Time PCR System (Applied Biosystems).
For each assay 45 PCR cycles were run (95°C for 3 sec
and 60°C for 30 sec) and a dissociation curve was in-
cluded at the end of the reaction to verify the amplifica-
tion of a single PCR product. Analyses of amplification
plots were performed with the 7500 Software (Applied
Biosystems). Each assay plate included a negative con-
trol. The coefficient of variation was below 5% for all the
primer pairs used. Relative expression was calculated
from the equation 2A−B/2C−D (where A is the cycle
threshold [Ct] number for the gene of interest in the
first control sample; B, the Ct number for the gene of
interest in the analyzed sample; C, the Ct number for β2
microglobulin in the first control sample; D, the Ct
number for β2 microglobulin in the analyzed sample).
The first control sample was expressed as 1.00 by this
equation, and all other samples were calculated in rela-
tion to this value. Afterward, the results in the control
group (normal young mice) were averaged, and all other
outputs were divided by the mean value of the relative
expression in the control group to yield the fold change
of the genes of interest expression compared to the
control group [28].Figure 2 Ovarian gene expression for genes in the GH signaling path
bar) normal (N) and Ames dwarf (df/df) mice. Different letter indicate si
lower in old than younger mice (P<0.05).For the immunohistochemistry (IHC) analysis, ovaries
from 12-month old N (n = 4) and Ames dwarf (n = 4)
were collected and embedded in paraffin. After that,
3 μm slices obtained in an automatic microtome were
adhered in slides impregnated by 3% organosilane
(Sigma Chemical Company®, St. Louis, MO, USA) in
ethanol. The samples were deparaffinized with xylene and
rehydrated with graded alcohols. The primary polyclonal
antibodies were: anti-Foxo3 phosphorylated (p-Foxo3)
[p-FKHRL1 antibody; Ser 253, sc-101683-rabbit (IgG)]
and anti-Foxo3 [FKHRL1 antibody; N16, sc-101683-goat
(IgG)], both diluted 1:50. The primary antibodies were
obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA) and diluted in 1.5% BSA solution. Blockage of
the endogenous peroxidase activity was conducted with
hydrogen peroxide block solution (Spring Bioscience,
Pleasanton, CA, USA), whereas the antigenic recovery
was performed in humid heat, during 3 min after the boil-
ing point, in citrate solution pH 6.0. Non-specific back-
ground staining was reduced by covering the tissue
sections that received protein block (Spring Bioscience,
Pleasanton, CA, USA). Thereafter, slides were incubated
overnight in a humid chamber at 4°C. Slides with p-
Foxo3 antibody were instilled with Reveal Polyvalente
HRP® Kit (Spring Bioscience, Pleasanton, CA, USA) andway in young (6 months–black bar) and old (22 months–grey
gnificant differences (P<0.05). Expression of all genes showed was
Figure 3 Ovarian gene expression for genes indicating ovarian
activity (AMH, GDF9 and BMP15) in young (6 months–black bar)
and old (22 months–grey bar) normal (N) and Ames dwarf (df/df)
mice. Different letter indicate significant differences (P<0.05). Expression
of all genes showed was lower in old than younger mice (P<0.05).
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(Nichirei Bioscience, Tokyo, Japan). Slides were incubated
at room temperature, with 3,3’ diaminobenzidine (DAB-K3468, Dako Corporation, Carpinteria, CA, USA),
counterstained with Mayer’s hemalum solution (Merck,
Darmstadt, Germany) and mounted with coverslips and
synthetic resin (Sigma Chemical Company®, St. Louis,
MO, USA). The same technician conducted all proce-
dures for IHC.
Images of ovarian sections were captured with a
digital camera (Olympus DP72) attached to a compound
light microscope (Olympus BX 51, Tokyo, Japan), using
the 40 X objective. Only oocytes included in primordial,
primary and secondary follicles were marked for image
analysis and the intensity of labeling was captured. The
oocytes were classified as: included in primordial/pri-
mary follicles (OIPF), when surrounded by one layer of
flat or cubic granulosa cells and included in secondary
follicles (OISF), when surrounded by two or more layers
of cubic granulosa cells [29]. For the Foxo3 antibody a
total of 28 OIPF (14 N and 14 df/df ) and 8 OISF (4 N
and 4 df/df ) were analyzed; and for the evaluation of p-
Foxo3 immunostaining 30 OIPF (15 N and 15 df/df )
and 9 OISF (4 N and 5 df/df ) were used. Protein quanti-
fication was performed by software image analysis
[30-33]. The most common value (the mode) of each
area was registered by the 32-bit histogram application
of the Image J® software, using a scale ranging from 0
(the greatest staining intensity) to 255 (no staining) that
was converted to a percentual scale from 0% (no staining)
to 100% (greatest staining).
The results are presented as mean ± standard error of the
mean (SEM). All statistical analyses were performed using
Graphpad Prism 5 (Graphpad Software Inc., La Jolla, CA,
USA). One-way ANOVA was performed to estimate
between groups difference, followed by Tukey’s multiple
comparison test. Immunostaining intensity for FOXO3
and p-FOXO3 was compared between strains by t-test.
A P value lower than 0.05 was considered statistically
significant.
All animal procedures employed in our presented
work were approved by the Laboratory Animal Care and
Use Committee (LACUC) at the Southern Illinois Uni-
versity School of Medicine (Springfield, IL).
Results
The expression of insulin receptor substrate 1 (Irs1), Pi3k,
Akt1, Mtor, suppressor of cytokine signaling −2 (Socs2),
Socs3 was lower (P < 0.05) in older than younger N mice
(Figures 1 and 2). Despite that, the expression of Irs1,
Pi3k, Akt1, Mtor, Socs2, Socs3 was not different (P > 0.05)
between young and old df/df mice (Figures 1 and 2). The
expression of Foxo3a was also lower (P < 0.05) in old than
younger N and df/df mice. In addition, Foxo3a expression
was higher (P < 0.05) in old df/df than N mice. The ex-
pression of Ghr and Igf was lower (P < 0.05) in old than
young df/df mice. Despite that, expression Ghr and
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N mice. Expression of Amh was lower (P < 0.05) in old
than young N and df/df mice. In addition Amh expression
was higher (P = 0.0009) in df/df than N mice. Expression
of Bmp15 was lower (P < 0.05) in old than young N mice,
but not different (P > 0.05) between old and young df/df
mice. Expression of Gdf9 was lower (P < 0.05) in old than
young df/df mice, but not different (P > 0.05) between old
and young N mice (Figures 3).
Foxo3 and p-Foxo3 immunostaining for OIPF and
OISF in df/df and N mice is shown in Figures 4 and 5. It
was observed that there was no difference between df/df
and N mice for Foxo3 immunostaining in OIPF and
OISF (P > 0.05). However, immunostaining for p-Foxo3
was higher in N vs df/df mice in OIPF (P = 0.0008), and
there was no difference (P = 0.09) when comparing N vs
Ames dwarf mice in OISF.
Discussion
Expression of mRNA for Irs1, Socs2, Socs3, Akt1, Pi3k,
Mtor and Foxo3a was lower in the ovaries of older mice
of both genotypes. As mentioned earlier, activation of
this pathway by growth factors is involved in theFigure 4 Immunostaining for FOXO3 and p-FOXO3 in oocytes from p
normal (N) and Ames dwarf (df/df) mice.activation of primordial follicle growth by ultimately pro-
moting phosphorylation and nuclear export of FOXO3a
[20,22]. The lower expression of these genes in older mice
points to this pathway as associated with the process of
ovarian aging and follicle depletion. In fact, a recent study
indicate that down-regulation of oocyte FOXO3a expres-
sion is essential for follicle progression from the primor-
dial to later stages of development [34]. Older mice also
had lower mRNA expression for Amh, Gdf9 and Bmp15.
The AMH is a member of the transforming growth factor
β family (TGFβ) exclusively produced by granulosa cells
(GC) of developing preantral and small antral follicles
[35]. Serum AMH levels are widely used to estimate the
size of the ovarian reserve [36]. GDF9 and BMP15 are also
members of the TGFβ family and produced exclusively by
growing oocytes in the mice ovary [37,38]. In the GDF9
null mice folliculogenesis does not progress beyond the
primary stage [39], while BMP15 null mice had impaired
oocyte maturation leading to infertility [40]. Therefore,
both GDF9 and BMP15, in addition to AMH, are indicat-
ing lower ovarian activity in 22-month-old in relation to
6-month-old mice of both genotypes as we would expect
during aging of the ovaries. Together, these resultsrimordial/primary and secondary follicles from 12-month old
Figure 5 Immunostaining (arrows) for FOXO3 (A-D) and p-FOXO3 (E-H) in oocytes included in primordial/primary follicles (OIPF) and
oocytes included in secondary follicles (OISF) in N mice (A, C, E and G) and df/df mice (B, D, F and H). Negative controls are represented in
small Figures a-h. OIPF immunostained with FOXO3 in N and df/df mice, respectively. (Photomicrograph 100 X). (C and D) OISF immunostained
with FOXO3 in N and df/df mice, respectively (photomicrograph 10 X). (E and F) OIPF immunostained with pFOXO3 in N and df/df mice,
respectively. (Photomicrograph 100 X). (G and H) OISF immunostained with pFOXO3 in N and df/df mice, respectively. (Photomicrograph 10 X).
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is associated with reduced expression of the members of
the IRS1-Pi3k-Akt1-FOXO3 pathway.
Interestingly, expression of Foxo3a mRNA was 10-fold
higher in the ovaries of old df/df mice when comparing
to old N mice. FOXO3a is crucial in the maintenance of
follicles in the primordial quiescent stage while not
phosphorylated [22]. Therefore, the higher expression ofFoxo3a indicates that follicles could be trapped in the
primordial stage. This was confirmed by the observation
that oocytes from primordial/primary follicles from
Ames dwarf mice had a lower level of p-FOXO3 com-
pared to N mice, although no difference in the level of
FOXO3 was detected, indicating a lower level of activa-
tion of primordial follicles. It is known that phosphoryl-
ation of FOXO3a by the IRS-Pi3k-Akt pathway is what
Schneider et al. Journal of Ovarian Research  (2014) 7:120 Page 8 of 9indicates its activation, therefore higher gene expression
from members of the IRS-Pi3k-Akt pathway does not
necessarily means more FOXO3a activation, because it
depends on the level of activation of this pathway by in-
sulin/IGF. Since Ames dwarf mice have strongly reduced
insulin/IGF signaling [3], it is possible that this is the
cause of the reduced level of p-FOXO3 in oocytes from
Ames dwarf mice. This hypothesis agree with histological
observations in long-living GH-resistant GHRKO mice and
mice subjected to calorie restriction where a higher number
of follicles in the primordial stage is observed concomi-
tantly with less follicles in the primary, secondary and ter-
tiary stages [16,18]. A recent paper has demonstrated that
oocyte expression of a constitutively active form of FOXO3
in a transgenic mouse model is associated with a younger
ovarian phenotype [41]. In this way FOXO3a is been re-
ferred as a potential determinant of the onset of meno-
pause, as well as a potential agonist intervention to reduce
the physiological decline in female fertility at later ages [41].
Therefore our study, in agreement with previous obser-
vations [41], indicates that higher expression of Foxo3a
mRNA and decreased level of p-FOXO3 in oocytes from
primordial/primary follicles, together with other genes
in the pathway of insulin signaling as observed in df/
df mice, is associated to increased expression of genes
related to follicle recruitment and growth (Amh, Gdf9
and Bmp15). Amh mRNA expression was about 80
times higher in old df/df when compared to old N
mice. This result indicates that although normal old
mice had severely depleted the ovarian follicular re-
serve (Amh mRNA expression about 900 times lower
than young N mice), df/df mice still have some follicu-
lar activity (Amh mRNA expression about 20 times
lower than young df/df mice). More studies are neces-
sary to identify if the same pattern will be observed in
GHRKO and calorie restricted N mice, but already
points that modulation of the IRS-Pi3k-Akt pathway
can modulate ovarian FOXO3a expression and there-
fore help in preventing follicle loss in older females.
Even though the liver is the main source of circulat-
ing IGF-I, many local tissues are able to produce IGF-I
[42]. The importance of the endocrine versus the para-
crine/autocrine ovarian IGF-I has been debated since
the demonstration that GHRKO mice [15] and mice
with liver-specific knockout of IGF-I [43] are able to re-
produce, while the IGF-I null mice are infertile and fail
to ovulate [44]. In this way, the data of the present
study further support these findings by showing that
df/df mice, that have no detectable levels of circulating
GH and severely reduced IGF-I, are able to produce
ovarian Igf1 mRNA. The results indicate that ovarian
Igf1 mRNA expression is largely independent of GH as
demonstrated in the df/df mice hippocampus [10] and
in the ovaries of GHRKO mice [11].Conclusions
In sum, the present study indicates that lower expression
of Irs1, Socs2, Socs3, Akt1, Pi3k, Mtor and Foxo3a
mRNA in the ovaries of older mice of both genotypes is
associated to a reduced ovarian activity revealed by
lower expression of Amh mRNA. At the same time, ovar-
ies of old df/df mice maintained higher expression of
Foxo3a mRNA, which was associated to higher ovarian
activity. We have shown that df/df females have a lower
level of p-FOXO3 in oocytes from primordial/primary fol-
licles, an important activator of follicular growth. There-
fore, our study strongly indicates that Prop1df mutation
causes delayed ovarian aging.
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